Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial
- DOI
- 10.1016/j.annonc.2023.10.003
- Published
- 2024-01
- Container
- Annals of Oncology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.annonc.2023.10.003,
title = {Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial},
author = {A.O. Siefker-Radtke and N. Matsubara and S.H. Park and R.A. Huddart and E.F. Burgess and M. Özgüroğlu and B.P. Valderrama and B. Laguerre and U. Basso and S. Triantos and S. Akapame and Y. Kean and K. Deprince and S. Mukhopadhyay and Y. Loriot and Patricia Bastick and Sanjeev Sewak and Ben Tran and Martin Pichler and Shahrokh Shariat and Sylvie Rottey and Peter Schatteman and Dirk Schrijvers and Vincent Verschaeve and Christof Vulsteke and Luiza Aleixo Barros Leite Ferreira and Pereira de Santana Gomes Andrea Juliana and Joao Antonio Junior and Sergio Azevedo and Diogo Bastos and Giuliano Borges and Aldo Dettino and Pires Luis Antonio and Murilo Luz and Suelen Martins and Jose Mauricio Mota and Joseane Toledo and Bernhard Eigl and Daygen Finch and Joel Gingerich and Haiying Dong and Jian Huang and Jie Jin and Hongming Pan and Zhongquan Sun and Ye Tian and Ben Wan and Bin Wu and Ting Xu and Wei Xue and Fangjian Zhou and Philippe Barthelemy and Delphine Borchiellini and Fabien Calcagno and Aurelien Carnot and Pierre Cornillon and Remy Delva and Sheik Emambux and Nadine Houede and Brigitte Laguerre and Géraldine Lauridant and Yohann Loriot and Hakim Mahammedi and Denis Maillet and Damien Pouessel and Guilhem Roubaud and Friederike Schlurmann-Constans and Diego Tosi and Sylvie Zanetta and Severine Banek and Susan Feyerabend and Mario Kramer and Guenther Niegisch and Philipp Nuhn and Marco Schnabel and Christian Wuelfing and Sofia Baka and Aristotelis Bamias and George Fountzilas and Harabolos Kalofonos and Konstantinos Karalis and Athanasios Kotsakis and Eleni Timotheadou and Laszlo Landherr and Laszlo Mangel and Avivit Pe’er and Meital Levratovsky and Umberto Basso and Nicola Battelli and Alessia Cavo and Ugo De Giorgi and Laura Doni and Luca Galli and Maria Olga Gigante and Valentina Guadalupi and Michele Maio and Laura Milesi and Franco Nolè and Giorgio Scagliotti and Giampaolo Tortora and Satoshi Fukasawa and Toru Harabayashi and Naoto Kamiya and Takashi Kawahara and Mutsushi Kawakita and Nobunaki Matsubara and Kazumasa Matsumoto and Kazuo Nishimura and Taoka Rikiya and Nobuaki Shimizu and Toshio Tagaki and Taek Won Kang and Jwa Hoon Kim and SeHyun Kim and Hyo Jin Lee and Yun-Gyoo Lee and Sun Young Rha and Ho Kyung Seo and Maartje Los and Bogdan Zurawski and Paulo Cortes and Catia Faustino and Nuno Sineiro Vau and Ricardo da Luz and Vagif Atduev and Dmitry Kirtbaya and Evgeny Kopyltsov and Aleksandr Lykov and Urmantsev Marat and Sergey Orlov and Konstantin Penkov and Albert Pirmagomedov and Andrey Semenov and Sergey Varlamov and Georgia Anguera and Montserrat Domenech and Regina Girones and Aranzazu Gonzalez del Alba and Nuria Lainez Milagro and Raquel Luque and Esther Martínez Ortega and Begoña Mellado and María Jose Méndez Vidal and Esteban Nogales Fernandez and Begoña Perez Valderrama and Alvaro Pinto Marín and Carmen Santander and Yi-Hsiu Huang and Wen-Pin Su and Hung-Chan Wu and WenJeng Wu and Kai-Jie Yu and Ahmet Bilici and Erdem Goker and Mahmut Gumus and Aziz Karaoglu and Umut Kefeli and Fatih Köse and Mustafa Ozguroglu and Deniz Tural and Haci Turk and Suayib Yalcin and Igor Bondarenko and Gennadii Khareba and Yana Kidik and Oleksandr Lychkovskyy and Valerii Sakalo and Serghii Shevnia and Eduard Stakhovskyy and Amit Bahl and Simon Crabb and Thomas Powles and Peter Sankey and Mohammad Sarwar and Pasquale Benedetto and Earle Burgess and Nancy Dawson and Gurjyot Doshi and Mark Fleming and Joseph Maly and Mamta Parikh and David Waterhouse},
year = {2024},
journal = {Annals of Oncology},
doi = {10.1016/j.annonc.2023.10.003},
url = {https://doi.org/10.1016/j.annonc.2023.10.003}
}RIS
TY - JOUR TI - Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial AU - A.O. Siefker-Radtke AU - N. Matsubara AU - S.H. Park AU - R.A. Huddart AU - E.F. Burgess AU - M. Özgüroğlu AU - B.P. Valderrama AU - B. Laguerre AU - U. Basso AU - S. Triantos AU - S. Akapame AU - Y. Kean AU - K. Deprince AU - S. Mukhopadhyay AU - Y. Loriot AU - Patricia Bastick AU - Sanjeev Sewak AU - Ben Tran AU - Martin Pichler AU - Shahrokh Shariat AU - Sylvie Rottey AU - Peter Schatteman AU - Dirk Schrijvers AU - Vincent Verschaeve AU - Christof Vulsteke AU - Luiza Aleixo Barros Leite Ferreira AU - Pereira de Santana Gomes Andrea Juliana AU - Joao Antonio Junior AU - Sergio Azevedo AU - Diogo Bastos AU - Giuliano Borges AU - Aldo Dettino AU - Pires Luis Antonio AU - Murilo Luz AU - Suelen Martins AU - Jose Mauricio Mota AU - Joseane Toledo AU - Bernhard Eigl AU - Daygen Finch AU - Joel Gingerich AU - Haiying Dong AU - Jian Huang AU - Jie Jin AU - Hongming Pan AU - Zhongquan Sun AU - Ye Tian AU - Ben Wan AU - Bin Wu AU - Ting Xu AU - Wei Xue AU - Fangjian Zhou AU - Philippe Barthelemy AU - Delphine Borchiellini AU - Fabien Calcagno AU - Aurelien Carnot AU - Pierre Cornillon AU - Remy Delva AU - Sheik Emambux AU - Nadine Houede AU - Brigitte Laguerre AU - Géraldine Lauridant AU - Yohann Loriot AU - Hakim Mahammedi AU - Denis Maillet AU - Damien Pouessel AU - Guilhem Roubaud AU - Friederike Schlurmann-Constans AU - Diego Tosi AU - Sylvie Zanetta AU - Severine Banek AU - Susan Feyerabend AU - Mario Kramer AU - Guenther Niegisch AU - Philipp Nuhn AU - Marco Schnabel AU - Christian Wuelfing AU - Sofia Baka AU - Aristotelis Bamias AU - George Fountzilas AU - Harabolos Kalofonos AU - Konstantinos Karalis AU - Athanasios Kotsakis AU - Eleni Timotheadou AU - Laszlo Landherr AU - Laszlo Mangel AU - Avivit Pe’er AU - Meital Levratovsky AU - Umberto Basso AU - Nicola Battelli AU - Alessia Cavo AU - Ugo De Giorgi AU - Laura Doni AU - Luca Galli AU - Maria Olga Gigante AU - Valentina Guadalupi AU - Michele Maio AU - Laura Milesi AU - Franco Nolè AU - Giorgio Scagliotti AU - Giampaolo Tortora AU - Satoshi Fukasawa AU - Toru Harabayashi AU - Naoto Kamiya AU - Takashi Kawahara AU - Mutsushi Kawakita AU - Nobunaki Matsubara AU - Kazumasa Matsumoto AU - Kazuo Nishimura AU - Taoka Rikiya AU - Nobuaki Shimizu AU - Toshio Tagaki AU - Taek Won Kang AU - Jwa Hoon Kim AU - SeHyun Kim AU - Hyo Jin Lee AU - Yun-Gyoo Lee AU - Sun Young Rha AU - Ho Kyung Seo AU - Maartje Los AU - Bogdan Zurawski AU - Paulo Cortes AU - Catia Faustino AU - Nuno Sineiro Vau AU - Ricardo da Luz AU - Vagif Atduev AU - Dmitry Kirtbaya AU - Evgeny Kopyltsov AU - Aleksandr Lykov AU - Urmantsev Marat AU - Sergey Orlov AU - Konstantin Penkov AU - Albert Pirmagomedov AU - Andrey Semenov AU - Sergey Varlamov AU - Georgia Anguera AU - Montserrat Domenech AU - Regina Girones AU - Aranzazu Gonzalez del Alba AU - Nuria Lainez Milagro AU - Raquel Luque AU - Esther Martínez Ortega AU - Begoña Mellado AU - María Jose Méndez Vidal AU - Esteban Nogales Fernandez AU - Begoña Perez Valderrama AU - Alvaro Pinto Marín AU - Carmen Santander AU - Yi-Hsiu Huang AU - Wen-Pin Su AU - Hung-Chan Wu AU - WenJeng Wu AU - Kai-Jie Yu AU - Ahmet Bilici AU - Erdem Goker AU - Mahmut Gumus AU - Aziz Karaoglu AU - Umut Kefeli AU - Fatih Köse AU - Mustafa Ozguroglu AU - Deniz Tural AU - Haci Turk AU - Suayib Yalcin AU - Igor Bondarenko AU - Gennadii Khareba AU - Yana Kidik AU - Oleksandr Lychkovskyy AU - Valerii Sakalo AU - Serghii Shevnia AU - Eduard Stakhovskyy AU - Amit Bahl AU - Simon Crabb AU - Thomas Powles AU - Peter Sankey AU - Mohammad Sarwar AU - Pasquale Benedetto AU - Earle Burgess AU - Nancy Dawson AU - Gurjyot Doshi AU - Mark Fleming AU - Joseph Maly AU - Mamta Parikh AU - David Waterhouse PY - 2024 JO - Annals of Oncology DO - 10.1016/j.annonc.2023.10.003 UR - https://doi.org/10.1016/j.annonc.2023.10.003 ER -
APA
Siefker-Radtke, A., Matsubara, N., Park, S., Huddart, R., Burgess, E., Özgüroğlu, M., Valderrama, B., Laguerre, B., Basso, U., Triantos, S., Akapame, S., Kean, Y., Deprince, K., Mukhopadhyay, S., Loriot, Y., Bastick, P., Sewak, S., Tran, B., Pichler, M., Shariat, S., Rottey, S., Schatteman, P., Schrijvers, D., Verschaeve, V., Vulsteke, C., Ferreira, L. A. B. L., Juliana, P. D. S. G. A., Junior, J. A., Azevedo, S., Bastos, D., Borges, G., Dettino, A., Antonio, P. L., Luz, M., Martins, S., Mota, J. M., Toledo, J., Eigl, B., Finch, D., Gingerich, J., Dong, H., Huang, J., Jin, J., Pan, H., Sun, Z., Tian, Y., Wan, B., Wu, B., Xu, T., Xue, W., Zhou, F., Barthelemy, P., Borchiellini, D., Calcagno, F., Carnot, A., Cornillon, P., Delva, R., Emambux, S., Houede, N., Laguerre, B., Lauridant, G., Loriot, Y., Mahammedi, H., Maillet, D., Pouessel, D., Roubaud, G., Schlurmann-Constans, F., Tosi, D., Zanetta, S., Banek, S., Feyerabend, S., Kramer, M., Niegisch, G., Nuhn, P., Schnabel, M., Wuelfing, C., Baka, S., Bamias, A., Fountzilas, G., Kalofonos, H., Karalis, K., Kotsakis, A., Timotheadou, E., Landherr, L., Mangel, L., Pe’er, A., Levratovsky, M., Basso, U., Battelli, N., Cavo, A., Giorgi, U. D., Doni, L., Galli, L., Gigante, M. O., Guadalupi, V., Maio, M., Milesi, L., Nolè, F., Scagliotti, G., Tortora, G., Fukasawa, S., Harabayashi, T., Kamiya, N., Kawahara, T., Kawakita, M., Matsubara, N., Matsumoto, K., Nishimura, K., Rikiya, T., Shimizu, N., Tagaki, T., Kang, T. W., Kim, J. H., Kim, S., Lee, H. J., Lee, Y., Rha, S. Y., Seo, H. K., Los, M., Zurawski, B., Cortes, P., Faustino, C., Vau, N. S., Luz, R. D., Atduev, V., Kirtbaya, D., Kopyltsov, E., Lykov, A., Marat, U., Orlov, S., Penkov, K., Pirmagomedov, A., Semenov, A., Varlamov, S., Anguera, G., Domenech, M., Girones, R., Alba, A. G. D., Milagro, N. L., Luque, R., Ortega, E. M., Mellado, B., Vidal, M. J. M., Fernandez, E. N., Valderrama, B. P., Marín, A. P., Santander, C., Huang, Y., Su, W., Wu, H., Wu, W., Yu, K., Bilici, A., Goker, E., Gumus, M., Karaoglu, A., Kefeli, U., Köse, F., Ozguroglu, M., Tural, D., Turk, H., Yalcin, S., Bondarenko, I., Khareba, G., Kidik, Y., Lychkovskyy, O., Sakalo, V., Shevnia, S., Stakhovskyy, E., Bahl, A., Crabb, S., Powles, T., Sankey, P., Sarwar, M., Benedetto, P., Burgess, E., Dawson, N., Doshi, G., Fleming, M., Maly, J., Parikh, M., & Waterhouse, D. (2024). Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial. Annals of Oncology. https://doi.org/10.1016/j.annonc.2023.10.003
Source records
- crossref · retrieved 2026-09-25T21:20:28.395Z